CRP shown to predict heart disease among patients with metabolic syndrome
Source: Harvard Gazette, Circulation
A study found that women diagnosed with metabolic syndrome who have higher levels of C-reactive protein (CRP) are two times more likely to experience heart problems than women with metabolic syndrome with lower levels of CRP. These findings are in line with previous studies, which link high CRP levels to increased risk of heart attack, stroke, and Type II diabetes.
With an estimated 50 million Americans at risk of being diagnosed with metabolic syndrome, this study suggests that CRP testing can help determine if a person is at low, moderate, or high risk of experiencing a cardiovascular event.